Clinical Trials Logo

Seizures clinical trials

View clinical trials related to Seizures.

Filter by:

NCT ID: NCT00616681 Completed - Epilepsy Clinical Trials

Bioequivalency Study of 600 mg Oxcarbazepine Tablets Under Fasting Conditions

Start date: June 2004
Phase: N/A
Study type: Interventional

The objective of this study was to assess the bioequivalence of a potential generic 600 mg oxcarbazepine tablet formulation compared with Novartis Pharmaceutical's 600 mg oxcarbazepine tablet, Trileptal, following a single 600 mg dose administered under fasting conditions.

NCT ID: NCT00615615 Completed - Epilepsy Clinical Trials

Efficacy and Tolerability of Levetiracetam Add-On Treatment in Refractory Pediatric Patients With Partial Onset Seizures

Start date: September 1999
Phase: Phase 3
Study type: Interventional

Double-blind, randomized, placebo-controlled, multi-center clinical trial conducted to evaluate levetiracetam as adjunctive therapy in children (4-16 years) with refractory partial onset seizures.

NCT ID: NCT00603473 Completed - Epilepsies, Partial Clinical Trials

A Phase III Open-Label Study Of Gabapentin As Adjunctive Therapy In Japanese Pediatric Patients With Partial Seizures

Start date: January 2008
Phase: Phase 3
Study type: Interventional

Examine the efficacy, safety and pharmacokinetics of gabapentin as adjunctive therapy in Japanese pediatric patients with partial seizures

NCT ID: NCT00596466 Completed - Epilepsy Clinical Trials

Extension Study Of Long-Term Safety And Efficacy Of Pregabalin As Monotherapy (Lyrica) In Patients With Partial Seizures

Start date: April 2008
Phase: Phase 3
Study type: Interventional

This study will evaluate the long term safety and efficacy of pregabalin (Lyrica) when administered by itself (without any other anti-epileptic medication) to epilepsy patients for the treatment of partial seizures. This is an extension study to a previous clinical trial.

NCT ID: NCT00568217 Completed - Clinical trials for Recurrence of Febrile Seizure

Antipyretics for Preventing Recurrences of Febrile Seizures

Start date: September 1997
Phase: Phase 4
Study type: Interventional

We wanted to find out if the early use of antipyretics is capable in preventing recurrences of febrile seizures. When a child has had his/her first febrile seizure, the parents were instructed to give him/her antipyretic medication every time when the child had a new episode of fever during two years.

NCT ID: NCT00567424 Withdrawn - Epilepsy Clinical Trials

GW273225 Therapy Added To Current Seizure Treatments In Patients With Partial Seizures

Start date: July 2006
Phase: Phase 2
Study type: Interventional

Study to determine drug interactions between GW273225 and the anticonvulsants valproate, carbamazepine or phenytoin

NCT ID: NCT00566254 Completed - Clinical trials for Epilepsy; Paediatric Partial Onset Seizures

Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)

Start date: December 2008
Phase: Phase 3
Study type: Interventional

The purpose of this study is to compare the safety and efficacy of zonisamide with placebo.

NCT ID: NCT00563459 Terminated - Epilepsy Clinical Trials

Carisbamate Retention Study (CaReS): Comparative Study on the Long Term Effectiveness, Safety and Tolerability of Carisbamate Compared to Two Other Frequently Prescribed Anti-epileptic Drugs (AEDs) in Patients With Epilepsy.

Start date: November 2007
Phase: Phase 3
Study type: Interventional

The purpose of this research study is to compare the long term effectiveness, safety and tolerability of carisbamate compared to two other frequently prescribed anti-epileptic drugs (AEDs) in patients with epilepsy.

NCT ID: NCT00552305 Completed - Partial Epilepsies Clinical Trials

To Determine Tolerability and Efficacy of Long-term Oral Lacosamide in Patients With Partial Seizures

Start date: August 2001
Phase: Phase 2
Study type: Interventional

The purpose of this trial is to determine whether lacosamide is safe and effective for long-term use in patients with partial-seizures from epilepsy.

NCT ID: NCT00545012 Completed - Absence Seizures Clinical Trials

A Safety and Efficacy Follow-up Study With Levetiracetam in Children (4-17 Years Old) Suffering From Absence Seizures

Start date: May 2000
Phase: Phase 2
Study type: Interventional

This long-term open label follow-up trial gave pediatric subjects suffering from typical absences in CAE or JAE the opportunity to continue levetiracetam treatment after participation in the pilot study (study N162) or the double-blind study (study N163). Safety and efficacy data were obtained.